AYV News, April 1, 2026
Sierra Leone is making measurable progress in its fight against HIV, but new findings indicate that these gains remain fragile and could stall without stronger reforms and sustained financing.
According to a recent report by the Joint United Nations Programme on HIV/AIDS, an estimated 77,000 people are currently living with HIV in Sierra Leone. The country records approximately 1,700 new infections and 1,800 AIDS-related deaths annually, underscoring the continuing public health challenge.
A separate peer-reviewed study published in the Annals of Global Health highlights both progress and critical gaps in the national response. The research shows that about 80 percent of people living with HIV are aware of their status, while 87 percent of those diagnosed are receiving treatment. However, only 44 percent of patients achieve viral suppression, revealing a significant gap in treatment effectiveness.
Health experts say this disparity points to systemic challenges, including recurring drug stockouts, persistent stigma, limited testing capacity, and weaknesses in health data systems. Heavy reliance on donor funding has also been identified as a major vulnerability, raising concerns about the long-term sustainability of HIV programmes.
While treatment coverage has improved in recent years—with roughly 83 percent of people living with HIV aware of their status and a similar proportion of those diagnosed on therapy—these figures still fall short of the global 95-95-95 targets set for 2030.
The report also highlights gender disparities in infection rates, noting that women are disproportionately affected by HIV in Sierra Leone. Despite these challenges, UNAIDS describes the country’s epidemic as “moderate but controlled,” citing declining mortality rates and expanded access to treatment services.
However, the study warns that without intensified efforts—particularly in scaling up testing, improving treatment adherence, reducing stigma, and increasing domestic investment in healthcare—Sierra Leone risks falling short of global HIV targets.
Analysts say the findings present a mixed picture: encouraging progress in diagnosis and treatment access, but persistent structural weaknesses that must be addressed to achieve long-term success in the fight against HIV.
